{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:05:46Z","timestamp":1776132346218,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T00:00:00Z","timestamp":1124841600000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1.\u2002Magnesium deficiency has recently been proposed as a novel factor implicated in the pathogenesis of the complications of diabetes. The purpose of the present study was to determine the relationship between oral Mg supplementation and changes in plasma glucose, calcium, haemogolobin, Ca\/Mg ratio, blood pressure and the histology of the pancreas and vascular system in streptozotocin\u2010induced diabetic rats.<\/jats:p><jats:p>2.\u2002Ten days after the induction of diabetes in male Wistar rats, half the diabetic animals were divided into six groups, receiving 0, 1, 3, 10, 30 or 50\u00a0g\/L MgSO<jats:sub>4<\/jats:sub> added into the drinking water for 8 weeks. Plasma glucose and Mg were measured at days 1, 2, 3, 5, 7, 14 and 21 to find the optimum dose of Mg and the time\u2010course of its effect. In addition, histological observations were undertaken. Eight weeks later, all animals were decapitated, the pancreas and thoracic aorta were removed carefully and immersed immediately in 10% formaldehyde for histological study.<\/jats:p><jats:p>3.\u2002To evaluate the effects of Mg on plasma glucose, calcium, haemoglobin, Mg and blood pressure, another group of animals was divided into four experimental groups, as follows: (i) non\u2010diabetic controls received tap water for 8 weeks; (ii) acute diabetics received tap water for 10 days; (iii) chronic diabetic controls received tap water for 8 weeks; and (iv) Mg\u2010treated chronic diabetic rats received 10\u00a0g\/L MgSO<jats:sub>4<\/jats:sub> added into the drinking water 10 days after the induction of diabetes for 8 weeks.<\/jats:p><jats:p>4.\u2002Magnesium dose dependently affects plasma glucose levels. The peak effect was reached during the first 24\u00a0h following oral administration. Administration of 10\u00a0g\/L MgSO<jats:sub>4<\/jats:sub> results in the return of normal structure in the diabetic pancreas and aorta. Moreover, this concentration of MgSO<jats:sub>4<\/jats:sub> causes glucose, haemoglobin, calcium, the Ca\/Mg ratio and blood pressure to reach normal levels. Although the Mg level increases slightly following the administration of 10\u00a0g\/L MgSO<jats:sub>4<\/jats:sub> to diabetic rats, it never reaches control levels.<\/jats:p><jats:p>5.\u2002On the basis of the results of the present study, it may be concluded that chronic Mg administration may have beneficial effects on diabetes.<\/jats:p>","DOI":"10.1111\/j.0305-1870.2005.04238.x","type":"journal-article","created":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T09:01:17Z","timestamp":1124874077000},"page":"604-610","source":"Crossref","is-referenced-by-count":30,"title":["EFFECTS OF ADMINISTRATION OF ORAL MAGNESIUM ON PLASMA GLUCOSE AND PATHOLOGICAL CHANGES IN THE AORTA AND PANCREAS OF DIABETIC RATS"],"prefix":"10.1111","volume":"32","author":[{"given":"Nepton","family":"Soltani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bagher","family":"Minaii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Mirershadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh Zahedi","family":"Asl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.2741\/1223"},{"key":"e_1_2_6_3_2","first-page":"1456","article-title":"Magnesium deficiency and diabetes mellitus","volume":"83","author":"Chetan PH","year":"2002","journal-title":"Curr. Sci."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601327"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-75-4-293"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(99)00005-4"},{"key":"e_1_2_6_7_2","first-page":"37","article-title":"Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus","volume":"51","author":"Lal J","year":"2003","journal-title":"J. Assoc. Physicians India"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2001.28072"},{"key":"e_1_2_6_9_2","first-page":"126","article-title":"Intracellular magnesium and insulin resistance","volume":"17","author":"Takaya J","year":"2004","journal-title":"Magnes. Res."},{"key":"e_1_2_6_10_2","first-page":"12","article-title":"Serum magnesium levels in non\u2010diabetic offspring of patients with type 2 diabetes mellitus","volume":"17","author":"Maltezos E","year":"2004","journal-title":"Diabetes Nutr. Metab."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00420-1"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(96)00342-1"},{"key":"e_1_2_6_13_2","first-page":"347","article-title":"Magnesium and cardiovascular biology an important link between cardiovascular risk factors and atherogenesis","volume":"41","author":"Altura BM","year":"1995","journal-title":"Cell. Mol. Biol. Res."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.5.1840"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1999.0576"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1992.11701494"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/089426801316970259"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018090-00003"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(97)00068-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(02)00065-1"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0305-1870.2005.04238.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0305-1870.2005.04238.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T23:23:37Z","timestamp":1696893817000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0305-1870.2005.04238.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.0305-1870.2005.04238.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0305-1870.2005.04238.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}